⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29465177 | 1.00 | — | — | |
| SCHEMBL29465156 | 1.00 | — | — | |
| SCHEMBL30041643 | 0.86 | — | — | |
| SCHEMBL30295004 | 0.86 | — | — | |
| SCHEMBL19348395 | 0.83 | — | — | |
| SCHEMBL30891809 | 0.77 | — | — | |
| SCHEMBL30891787 | 0.77 | — | — | |
| SCHEMBL3725339 | 0.74 | — | — | |
| SCHEMBL29187917 | 0.73 | HRH4 (0.32) | — | |
| SCHEMBL28950561 | 0.73 | HRH4 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611743-A1 | TRIAZINES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3 | Merck Sharp & Dohme LLC (US) | 2025-09-10 | — | — | EP | claimed |
| US-12384789-B2 | Compounds for treating Huntington's disease | PTC THERAPEUTICS, INC. (US) | 2025-08-12 | — | — | US | claimed |
| CN-119528903-A | Compounds for the treatment of spinal muscular atrophy | PTC医疗公司 | 2025-02-28 | — | — | CN | claimed |
| US-12157094-B2 | Gas separation method with multilayer membrane | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-12-03 | — | — | US | claimed |
| CN-108299314-B | Compounds for the treatment of spinal muscular atrophy | PTC医疗公司 | 2024-11-26 | — | — | CN | claimed |
| US-12138596-B2 | Method for separating carbon dioxide and methane | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-11-12 | — | — | US | claimed |
| US-12102966-B2 | CO2 gas enrichment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-10-01 | — | — | US | claimed |
| US-12102967-B2 | Method for separating a gas stream to isolate carbon dioxide | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-10-01 | — | — | US | claimed |
| CN-111065626-B | Compounds for the treatment of huntington's disease | PTC医疗公司 | 2024-09-27 | — | — | CN | claimed |
| US-20240278188-A1 | METHOD FOR SEPARATING CARBON DIOXIDE AND METHANE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-08-22 | — | — | US | claimed |
| EP-4151627-A1 | COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | PTC Therapeutics, Inc. (US) | 2023-03-22 | — | — | EP | claimed |
| US-11571665-B2 | Layered CDC-polyamide membrane and its make and use | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-02-07 | — | — | US | claimed |
| US-20220251098-A1 | COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS, INC. | 2022-08-11 | — | — | US | claimed |
| US-11382918-B2 | Methods for treating Huntington's Disease | PTC THERAPEUTICS, INC. (US) | 2022-07-12 | — | — | US | claimed |
| US-20200206695-A1 | LAYERED CDC-POLYAMIDE MEMBRANE AND ITS MAKE AND USE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-07-02 | — | — | US | claimed |
| CN-107567453-A | (base of indazole 4) hexahydropyrrolo and pyrrolones and application method | 艾伯维公司 | 2018-01-09 | — | — | CN | claimed |
| US-8669266-B2 | Quinoline-carboxamide derivatives as P2Y12 antagonists | SANOFI (FR) | 2014-03-11 | — | — | US | claimed |
| US-20100135999-A1 | QUINOLINE-CARBOXAMIDE DERIVATIVES AS P2Y12 ANTAGONISTS | SANOFI-AVENTIS (FR) | 2010-06-03 | — | — | US | claimed |
| EP-2148871-A1 | QUINOLINE-CARBOXAMIDE DERIVATIVES AS P2Y12 ANTAGONISTS | Sanofi-Aventis (FR) | 2010-02-03 | — | — | EP | claimed |
| WO-2008128647-A1 | QUINOLINE-CARBOXAMIDE DERIVATIVES AS P2Y12 ANTAGONISTS | SANOFI-AVENTIS (FR) | 2008-10-30 | — | — | WO | claimed |